Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 16, 2019

Sanofi to use Biomunex’s BiXAb platform to generate antibody therapeutics

Biomunex Pharmaceuticals has signed a licensing agreement with Sanofi for the development of bi-specific and multi-specific antibody therapeutics.

Continue
Image: Sanofi will use Biomunex’s BiXAb platform to generate and optimize antibody therapeutics. Photo: courtesy of Baitong333 / FreeDigitalPhotos.net.
January 15, 2019

Pfizer’s tafamidis secures FDA priority review for ATTR-CM

Image: Pfizer’s tafamidis meglumine form gets priority review from FDA for ATTR-CM. Photo: courtesy of Coolcaesar/Wikipedia.org.
January 14, 2019

Charles River, Atomwise collaborate on AI-driven drug discovery

Image: Charles River Laboratories and Atomwise have collaborated on AI-driven drug discovery capabilities. Photo: courtesy of Khotcharak / FreeDigitalPhotos.net.

Contracts

December 24, 2018

Lupin awards MALT1’s licensing rights to AbbVie

Electron microscopic image of a single human lymphocyte. Credit: Unknown photographer/artist.

Ixico secures expanded contract from major biopharmaceutical firm

hVIVO signs new contracts with global biopharmaceutical firm

Opiant signs contract with BARDA to accelerate OPTN003 product development

Deals

Deals January 14, 2019

Puma Biotechnology, Knight Therapeutics sign license deal to commercialize NERLYNX in Canada

Pharmaceutical Business Review

Takeda completes $62bn acquisition of Irish biotech firm Shire

Lilly to acquire Loxo Oncology for $8bn

Bristol-Myers Squibb to acquire Celgene for $74bn

Popular

  1. Bioharmony, Boehringer to advance bacteriophage lysin therapeutics to treat MDR bacterial infections
  2. Exelixis announces US FDA approval of CABOMETYX tablets for previously treated HCC
  3. Ascletis and Alphamab sign licensing deal for anti-PD-L1 to treat hepatitis B and other viral diseases
  4. Diurnal secures second US patent for Chronocort
  5. hVIVO achieves primary endpoint in phase II vaccine flu study

PRESS RELEASES

Novo Nordisk Pharmatech Signs Distribution Agreement With DKSH
Novo Nordisk Pharmatech Signs Distribution Agreement With DKSH
Try Mg Gummies at Vitafoods Europe
Try Mg Gummies at Vitafoods Europe
Webinar: When is a particle not a particle?
Webinar: When is a particle not a particle?
2019 IPEC Europe Annual Excipients Forum, Malta
2019 IPEC Europe Annual Excipients Forum, Malta
2019 Colorado Protein Stability Conference
2019 Colorado Protein Stability Conference

Suppliers

Whitepapers

Evaluating Gelatin and Enteric Coating Formulation Using QbD Approach
Evaluating Gelatin and Enteric Coating Formulation Using QbD Approach
NIR-Chemometric Method for Determining Gel Strength of Gelatin
NIR-Chemometric Method for Determining Gel Strength of Gelatin
Designing Wellness for Fun and Satisfaction
Designing Wellness for Fun and Satisfaction